Today's Top Stories | | By Ryan Hasson | July 3, 2025 06:07 AM |
| | By Wyatt Investment Research |
| | By The Associated Press | July 3, 2025 12:15 AM |
| | By Leo Miller | July 2, 2025 03:34 PM |
| | | By Jeffrey Neal Johnson | July 2, 2025 03:27 PM |
| | By Leo Miller | July 2, 2025 01:09 PM |
|
|
 | Recession Fears Mounting? 2 AI Stocks to Watch Now (ad)2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn't slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they're still flying below most investors' radar.
👉[Click here to access your FREE AI stocks report now.] |
|
Your Watchlist | | | | - Meta Platforms (NASDAQ:META) was upgraded by Needham & Company LLC (
  ) (analyst Laura Martin) from an "underperform" rating to a "hold" rating.The current price is $713.57. - CEO Mark Zuckerberg sold 13,793 shares of the company's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $723.89, for a total transaction of $9,984,614.77. Following the transaction, the chief executive officer directly owned 2,361 shares of the company's stock, valued at $1,709,104.29. This represents a 85.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
- COO Javier Olivan sold 517 shares of the company's stock in a transaction on Monday, June 30th. The shares were sold at an average price of $740.97, for a total value of $383,081.49. Following the completion of the transaction, the chief operating officer owned 7,853 shares of the company's stock, valued at approximately $5,818,837.41. This represents a 6.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
- CEO Mark Zuckerberg sold 2,361 shares of the company's stock in a transaction on Wednesday, July 2nd. The shares were sold at an average price of $716.48, for a total value of $1,691,609.28. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
- (7/3) Meta Platforms (NASDAQ:META) Rating Increased to Hold at Needham & Company LLC (marketbeat.com)
- (7/3) Meta Platforms (NASDAQ: META) Stock Price Prediction for 2025: Where Will It Be in 1 Year (July 3) (247wallst.com)
- (7/3) Insider Selling: Meta Platforms, Inc. (NASDAQ:META) COO Sells 517 Shares of Stock (insidertrades.com)
- (7/3) 5 Top Tech Stocks to Buy Right Now (fool.com)
- (7/3) Meta Platforms, Inc. (NASDAQ:META) Shares Sold by Mmbg Investment Advisors CO. (marketbeat.com)
| |
|
Manage Your Watchlist
|
Analysts' Upgrades | | FedEx (NYSE:FDX) was upgraded by analysts at BNP Paribas Exane from an "underperform" rating to an "outperform" rating. They now have a $270.00 price target on the stock. This represents a 11.5% upside from the current price of $242.21. | | Huntington Bancshares (NASDAQ:HBAN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock. This represents a 19.2% upside from the current price of $17.61. | | Meta Platforms (NASDAQ:META) was upgraded by analysts at Needham & Company LLC from an "underperform" rating to a "hold" rating.The current price is $717.35. | | United Parcel Service (NYSE:UPS) was upgraded by analysts at BNP Paribas Exane from an "underperform" rating to a "neutral" rating. They now have a $100.00 price target on the stock. This represents a 4.6% downside from the current price of $104.83. | | Valley National Bancorp (NASDAQ:VLY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $11.00 price target on the stock. This represents a 14.3% upside from the current price of $9.63. |
|
View More Upgrades
|
Analysts' New Coverage | | Absci (NASDAQ:ABSI) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $7.00 price target on the stock. This represents a 153.3% upside from the current price of $2.76. | | argenex (NASDAQ:ARGX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $700.00 price target on the stock. This represents a 29.0% upside from the current price of $542.83. | | Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $250.00 price target on the stock. This represents a 44.5% upside from the current price of $173.03. | | Axsome Therapeutics (NASDAQ:AXSM) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $190.00 price target on the stock. This represents a 78.7% upside from the current price of $106.31. | | BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $97.00 price target on the stock. This represents a 68.8% upside from the current price of $57.48. | | Certara (NASDAQ:CERT) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $16.00 price target on the stock. This represents a 40.9% upside from the current price of $11.36. | | Disc Medicine (NASDAQ:IRON) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $85.00 price target on the stock. This represents a 57.4% upside from the current price of $54.01. | | Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $70.00 price target on the stock. This represents a 55.8% upside from the current price of $44.93. | | Primoris Services (NASDAQ:PRIM) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $102.00 price target on the stock. This represents a 21.0% upside from the current price of $84.28. | | Recursion Pharmaceuticals (NASDAQ:RXRX) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $5.00 price target on the stock. This represents a 3.3% downside from the current price of $5.17. | | Sana Biotechnology (NASDAQ:SANA) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $12.00 price target on the stock. This represents a 299.1% upside from the current price of $3.01. | | Schrodinger (NASDAQ:SDGR) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $28.00 price target on the stock. This represents a 33.0% upside from the current price of $21.05. | | Telix Pharmaceuticals (NASDAQ:TLX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $23.00 price target on the stock. This represents a 43.0% upside from the current price of $16.09. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | View and add up to ten holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | | Join Now |
|
|
Apple Inc. (AAPL)
Amazon.com, Inc. (AMZN)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
Microsoft Corporation (MSFT)
0 Response to "🌎 Meta Platforms Upgraded, Primoris Services Initiated, BioMarin Pharmaceutical Initiated and more..."
Post a Comment